IL6 and renal fibrosis: VHH-0031, which can reduce the release of IL-6, TNF-α and TGF-β, is supposed to suppress renal fibrosis induced by EndMT and EMT in diabetic kidneys so as to improve renal injury and inhibit inflammatory response.